Hypoxia-Inducible Factor-1-Independent Regulation of Vascular Endothelial Growth Factor by Hypoxia in Colon Cancer

Cancer Research

Volumn 64, Issue 5, 2004, Pages 1765-1772

  Mizukami, Yusuke ^a   Li, Jingnan ^a   Zhang, Xiaobo ^a   Zimmer, Michael A ^a   Iliopoulos, Othon ^a   Chung, Daniel C ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1; MESSENGER RNA; TRANSCRIPTION FACTOR; VASCULOTROPIN; DNA BINDING PROTEIN; HIF1A PROTEIN, HUMAN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; NUCLEAR PROTEIN; VASCULOTROPIN A;

ARTICLE; COLON CANCER; CONTROLLED STUDY; DNA RESPONSIVE ELEMENT; GENE EXPRESSION REGULATION; GENE INDUCTION; GENE MUTATION; HUMAN; HUMAN CELL; HYPOXIA; KNOCKOUT GENE; ONCOGENE K RAS; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; REPORTER GENE; RNA INTERFERENCE; TUMOR VASCULARIZATION; CELL HYPOXIA; COLON TUMOR; GENETICS; NEOVASCULARIZATION (PATHOLOGY); ONCOGENE RAS; PHYSIOLOGY; TUMOR CELL LINE; VASCULARIZATION;

CELL HYPOXIA; CELL LINE, TUMOR; COLONIC NEOPLASMS; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, RAS; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; NEOVASCULARIZATION, PATHOLOGIC; NUCLEAR PROTEINS; PROMOTER REGIONS (GENETICS); TRANSCRIPTION FACTORS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 1642329821     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-03-3017     Document Type: Article

References (51)

1. Hanahan, D., and Folkman, J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell, 86: 353-364, 1996.
2. Kerbel, R. S. Tumor angiogenesis: past, present and the near future. Carcinogenesis (Lond.), 21: 505-515, 2000.
3. Ferrara, N. Role of vascular endothelial growth factor in physiologic and pathologic angiogenesis: therapeutic implications. Semin. Oncol., 29: 10-14, 2002.
4. Wong, M. P., Cheung, N., Yuen, S. T., Leung, S. Y., and Chung, L. P. Vascular endothelial growth factor is up-regulated in the early pre-malignant stage of colorectal tumour progression. Int. J. Cancer, 81: 845-850, 1999.
5. Zhang, X., Gaspard, J. P., and Chung, D. C. Regulation of vascular endothelial growth factor by the Wnt and K-ras pathways in colonic neoplasia. Cancer Res., 61: 6050-6054, 2001.
6. Takahashi, Y., Kitadai, Y., Bucana, C. D., Cleary, K. R., and Ellis, L. M. Expression of vascular endothelial growth factor and its receptor, KDR, correlates with vascularity, metastasis, and proliferation of human colon cancer. Cancer Res., 55: 3964-3968, 1995.
7. Hockel, M., and Vaupel, P. Tumor hypoxia: definitions and current clinical, biologic, and molecular aspects. J. Natl. Cancer Inst., 93: 266-276, 2001.
8. Bruick, R. K., and McKnight, S. L. A conserved family of prolyl-4-hydroxylases that modify HIF. Science (Wash. DC), 294: 1337-1340, 2001.
9. Lando, D., Peet, D. J., Whelan, D. A., Gorman, J. J., and Whitelaw, M. L. Asparagine hydroxylation of the HIF transactivation domain a hypoxic switch. Science (Wash. DC), 295: 858-861, 2002.
10. 2 tension. Proc. Natl. Acad. Sci. USA, 92: 5510-5514, 1995.
11. Zhong, H., De Marzo, A. M., Laughner, E., Lim, M., Hilton, D. A., Zagzag, D., Buechler, P., Isaacs, W. B., Semenza, G. L., and Simons, J. W. Overexpression of hypoxia-inducible factor 1a in common human cancers and their metastases. Cancer Res., 59: 5830-5835, 1999.
12. Sun, X., Kanwar, J. R., Leung, E., Lehnert, K., Wang, D., and Krissansen, G. W. Gene transfer of antisense hypoxia inducible factor-1a enhances the therapeutic efficacy of cancer immunotherapy. Gene Ther., 8: 638-645, 2001.
13. Semenza, G. L. HIF-1 and tumor progression: pathophysiology and therapeutics. Trends Mol. Med., 8: S62-67, 2002.
14. Kung, A. L., Wang, S., Klco, J. M., Kaelin, W. G., and Livingston, D. M. Suppression of tumor growth through disruption of hypoxia-inducible transcription. Nat. Med., 6: 1335-1340, 2000.
15. Ryan, H. E., Poloni, M., McNulty, W., Elson, D., Gassmann, M., Arbeit, J. M., and Johnson, R. S. Hypoxia-inducible factor-1a is a positive factor in solid tumor growth. Cancer Res., 60: 4010-4015, 2000.
16. Ryan, H. E., Lo, J., and Johnson, R. S. HIF-1a is required for solid tumor formation and embryonic vascularization. EMBO J., 17: 3005-3015, 1998.
17. Levy, A. P., Levy, N. S., and Goldberg, M. A. Post-transcriptional regulation of vascular endothelial growth factor by hypoxia. J. Biol. Chem., 271: 2746-2753, 1996.
18. Forsythe, J. A., Jiang, B. H., Iyer, N. V., Agani, F., Leung, S. W., Koos, R. D., and Semenza, G. L. Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol. Cell. Biol., 16: 4604-4613, 1996.
19. von Marschall, Z., Cramer, T., Hocker, M., Finkenzeller, G., Wiedenmann, B., and Rosewicz, S. Dual mechanism of vascular endothelial growth factor upregulation by hypoxia in human hepatocellular carcinoma. Gut., 48: 87-96, 2001.
20. Rak, J., Mitsuhashi, Y., Bayko, L., Filmus, J., Shirasawa, S., Sasazuki, T., and Kerbel, R. S. Mutant ras oncogenes upregulate VEGF/VPF expression: implications for induction and inhibition of tumor angiogenesis. Cancer Res., 55: 4575-4580, 1995.
21. Mukhopadhyay, D., Tsiokas, L., Zhou, X. M., Foster, D., Brugge, J. S., and Sukhatme, V. P. Hypoxic induction of human vascular endothelial growth factor expression through c-Src activation. Nature (Lond.), 375: 577-581, 1995.
22. Alfranca, A., Gutierrez, M. D., Vara, A., Aragones, J., Vidal, F., and Landazuri, M. O. c-Jun and hypoxia-inducible factor 1 functionally cooperate in hypoxia-induced gene transcription. Mol. Cell. Biol., 22: 12-22, 2002.
23. Koong, A. C., Chen, E. Y., Mivechi, N. F., Denko, N. C., Stambrook, P., and Giaccia, A. J. Hypoxic activation of nuclear factor-κB is mediated by a Ras and Raf signaling pathway and does not involve MAP kinase (ERK1 or ERK2). Cancer Res., 54: 5273-5279, 1994.
24. Schmedtje, J. F., Jr., Ji, Y. S., Liu, W. L., DuBois, R. N., and Runge, M. S. Hypoxia induces cyclooxygenase-2 via the NF-κB p65 transcription factor in human vascular endothelial cells. J. Biol. Chem., 272: 601-608, 1997.
25. Chen, C., Pore, N., Behrooz, A., Ismail-Beigi, F., and Maity, A. Regulation of glut1 mRNA by hypoxia-inducible factor-1. Interaction between H-ras and hypoxia. J. Biol. Chem., 276: 9519-9525, 2001.
26. Mazure, N. M., Chen, E. Y., Laderoute, K. R., and Giaccia, A. J. Induction of vascular endothelial growth factor by hypoxia is modulated by a phosphatidylinositol 3-kinase/ Akt signaling pathway in Ha-ras-transformed cells through a hypoxia inducible factor-1 transcriptional element. Blood, 90: 3322-3331, 1997.
27. Tischer, E., Mitchell, R., Hartman, T., Silva, M., Gospodarowicz, D., Fiddes, J. C., and Abraham, J. A. The human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternative exon splicing. J. Biol. Chem., 266: 11947-11954, 1991.
28. Khokhlatchev, A., Rabizadeh, S., Xavier, R., Nedwidek, M., Chen, T., Zhang, X. F., Seed, B., and Avruch, J. Identification of a novel Ras-regulated proapoptotic pathway. Curr. Biol., 12: 253-265, 2002.
29. Behre, G., Smith, L. T., and Tenen, D. G. Use of a promoterless Renilla luciferase vector as an internal control plasmid for transient co-transfection assays of Ras-mediated transcription activation. Biotechniques, 26: 24-26, 28, 1999.
30. Brummelkamp, T. R., Bernards, R., and Agami, R. A system for stable expression of short interfering RNAs in mammalian cells. Science (Wash. DC), 296: 550-553, 2002.
31. Hresko, R. C., Murata, H., Marshall, B. A., and Mueckler, M. Discrete structural domains determine differential endoplasmic reticulum to Golgi transit times for glucose transporter isoforms. J. Biol. Chem., 269: 32110-32119, 1994.
32. Jogi, A., Ora, I., Nilsson, H., Lindeheim, A., Makino, Y., Poellinger, L., Axelson, H., and Pahlman, S. Hypoxia alters gene expression in human neuroblastoma cells toward an immature and neural crest-like phenotype. Proc. Natl. Acad. Sci. USA, 99: 7021-7026, 2002.
33. Kondo, K., Klco, J., Nakamura, E., Lechpammer, M., and Kaelin, W. G., Jr. Inhibition of HIF is necessary for tumor suppression by the von Hippel-Lindau protein. Cancer Cell, 1: 237-246, 2002.
34. 2 sensing. Science (Wash. DC), 292: 464-468, 2001.
35. Tokunaga, T., Tsuchida, T., Kijima, H., Okamoto, K., Oshika, Y., Sawa, N., Ohnishi, Y., Yamazaki, H., Miura, S., Ueyama, Y., and Nakamura, M. Ribozyme-mediated inactivation of mutant K-ras oncogene in a colon cancer cell line. Br. J. Cancer, 83: 833-839, 2000.
36. Sodhi, A., Montaner, S., Miyazaki, H., and Gutkind, J. S. MAPK and Akt act cooperatively but independently on hypoxia inducible factor-1a in rasV12 upregulation of VEGF. Biochem. Biophys. Res. Commun., 287: 292-300, 2001.
37. Ellis, L. M., Staley, C. A., Liu, W., Fleming, R. Y., Parikh, N. U., Bucana, C. D., and Gallick, G. E. Down-regulation of vascular endothelial growth factor in a human colon carcinoma cell line transfected with an antisense expression vector specific for c-src. J. Biol. Chem., 273: 1052-1057, 1998.
38. Taylor, C. T., Furuta, G. T., Synnestvedt, K., and Colgan, S. P. Phosphorylation-dependent targeting of cAMP response element binding protein to the ubiquitin/ proteasome pathway in hypoxia. Proc. Natl. Acad. Sci. USA, 97: 12091-12096, 2000.
39. Tsujii, M., Kawano, S., Tsuji, S., Sawaoka, H., Hori, M., and DuBois, R. N. Cyclooxygenase regulates angiogenesis induced by colon cancer cells. Cell, 93: 705-716, 1998.
40. Bonazzi, A., Mastyugin, V., Mieyal, P. A., Dunn, M. W., and Laniado-Schwartzman, M. Regulation of cyclooxygenase-2 by hypoxia and peroxisome proliferators in the corneal epithelium. J. Biol. Chem., 275: 2837-2844, 2000.
41. Kotch, L. E., Iyer, N. V., Laughner, E., and Semenza, G. L. Defective vascularization of HIF-1a-null embryos is not associated with VEGF deficiency but with mesenchymal cell death. Dev. Biol., 209: 254-267, 1999.
42. Gradin, K., McGuire, J., Wenger, R. H., Kvietikova, I., fhitelaw, M. L., Toftgard, R., Tora, L., Gassmann, M., and Poellinger, L. Functional interference between hypoxia and dioxin signal transduction pathways: competition for recruitment of the Arnt transcription factor. Mol. Cell. Biol., 16: 5221-5231, 1996.
43. Carmeliet, P., Dor, Y., Herbert, J. M., Fukumura, D., Brusselmans, K., Dewerchin, M., Neeman, M., Bono, F., Abramovitch, R., Maxwell, P., Koch, C. J., Ratcliffe, P., Moons, L., Jain, R. K., Collen, D., Keshert, E., and Keshet, E. Role of HIF-1a in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis. Nature (Lond.), 394: 485-490, 1998.
44. 2 homeostasis by hypoxia-inducible factor 1a. Genes Dev., 12: 149-162, 1998.
45. Tsuzuki, Y., Fukumura, D., Oosthuyse, B., Koike, C., Carmeliet, P., and Jain, R. K. Vascular endothelial growth factor (VEGF) modulation by targeting hypoxia-inducible factor-1a→ hypoxia response element→ VEGF cascade differentially regulates vascular response and growth rate in tumors. Cancer Res., 60: 6248-6252, 2000.
46. Krishnamachary, B., Berg-Dixon, S., Kelly, B., Agani, F., Feldser, D., Ferreira, G., Iyer, N., LaRusch, J., Pak, B., Taghavi, P., and Semenza, G. L. Regulation of colon carcinoma cell invasion by hypoxia-inducible factor 1. Cancer Res., 63: 1138-1143, 2003.
47. Kaluz, S., Kaluzova, M., and Stanbridge, E. J. Expression of the hypoxia marker carbonic anhydrase IX is critically dependent on SP1 activity. Identification of a novel type of hypoxia-responsive enhancer. Cancer Res., 63: 917-922, 2003.
48. Kang, H. T., Ju, J. W., Cho, J. W., and Hwang, E. S. Downregulation of Sp1 activity through modulation of O-glycosylation by treatment with a low glucose mimetic, 2-deoxyglucose. J. Biol. Chem., 278: 51223-51231, 2003.
49. Bontemps, Y., Vuillermoz, B., Antonicelli, F., Perreau, C., Danan, J. L., Maquart, F. X., and Wegrowski, Y. Specific protein-1 is a universal regulator of UDP-glucose dehydrogenase expression: its positive involvement in transforming growth factor-β signaling and inhibition in hypoxia. J. Biol. Chem., 278: 21566-21575, 2003.
50. Pal, S., Datta, K., Khosravi-Far, R., and Mukhopadhyay, D. Role of protein kinase Cζ in Ras-mediated transcriptional activation of vascular permeability factor/vascular endothelial growth factor expression. J. Biol. Chem., 276: 2395-2403, 2001.
51. Blancher, C., Moore, J. W., Robertson, N., and Harris, A. L. Effects of ras and von Hippel-Lindau (VHL) gene mutations on hypoxia-inducible factor (HIF-1a, HIF-2a, and vascular endothelial growth factor expression and their regulation by the phosphatidylinositol 3′-kinase/Akt signaling pathway. Cancer Res., 61: 7349-7355, 2001.